Jyong Biotech - MENS Net Assets per Single Share

Graphic logo of Jyong Biotech Ltd (MENS)

The linear price action on the Jyong Biotech Ltd (MENS) chart correlates with the implementation of digital algorithms for laboratory sample analysis, where the indicator stands at -0.34. The company's revenues are based on the sale of phytotherapeutic agents, including the promising MCS-2 drug for BPH. Meanwhile, the business relies on ESG principles, employing eco-friendly extraction and responsible harvesting of plant raw materials to create its medications.

Jyong Biotech Limited (MENS): Share Book Value from 06/18/2025 to 10/28/2026

jyongbio.com - analytical breakdowns and key metrics (MENS)

- price and consensus price forecast:
Price Chart Jyong Biotech Corp|MENS - Broker Consensus Forecast
- market capitalization data:
Market Value Jyong Biotech Ltd|MENS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Jyong Biotech|MENS - Net Asset Value|Market Capitalization to Book Value Ratio jyongbio.com|MENS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Jyong Biotech Ltd|MENS - Long-Term Debt to Capital|Short-Term Debt to Equity Jyong Biotech|MENS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Jyong Biotech Ltd|MENS - Company Long-Term Liabilities|Company Short-Term Debts Jyong Biotech
Fundamental company valuation:Jyong Biotech Corp - MENS
Manufactured products of Jyong Biotech

Book value determines the intrinsic stability of Jyong Biotech Ltd (MENS) through the volume of net assets. This metric is calculated by dividing shareholders' equity by the number of shares outstanding, reflecting the actual value of the assets. The BVPS trend allows for the verification of accounting accuracy between reporting periods. Growth in this indicator confirms effective capital management, which is further supported by the optimization of pharmaceutical substance logistics, ensuring high supply profitability.

Competitors of Jyong Biotech Ltd (MENS)

Haleon Group (HLN) - Net Assets per Single Share|KVUE: Equity per Share|Verona Pharma plc - Net Assets per Single Share|LGND (ligand.com) - Net Assets per Share|Net Assets per Single Share Amneal AMRX|Share Book Value Perrigo Company PLC|Alvotech Corp (ALVO) - Book Value per Share|Accounting Value of a Share Liquidia Inc. (LQDA)|Book Value per Share GLPG (Galapagos NV)|anipharmaceuticals.com - Book Value per Share|Net Assets per Single Share MannKind (MNKD)|AMPH: Accounting Value of a Share|PCRX (Pacira) - Net Assets per Single Share|ARS Corp (SPRY) - Accounting Value per Share|TBPH (Theravance Biopharma) - Book Value per Share|Book Value per Share aquestive.com (AQST)|scPharmaceuticals Inc. (SCPH) - Accounting Value per Share|Accounting Value of a Share TECX (tectonictx.com)|TNXP: Net Assets per Single Share|SXTC - Net Asset Value per Share|Accounting Value per Share Eupraxia Pharma EPRX|BHST - Book Price of a Share|Book Value per Share eXoZymes EXOZ|Oramed Pharmaceuticals Inc. (ORMP) - Accounting Value of a Share|Book Value per Share ENTX (Entera Bio Ltd)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share CPIX (cumberlandpharma.com)|Net Assets per Single Share Quantum BioPharma (QNTM)|FGEN - Book Price of a Share|TELO (Telomir Pharma) - Accounting Value per Share|RANI: Net Asset Value per Share|Net Assets per Single Share SNYR|RLYB (Rallybio) - Net Asset Value per Share|Net Assets per Single Share Lexaria Bioscience Corp (LEXX)|Equity per Share Pulmatrix Inc|PTHL: Book Value per Share|Book Value of One Share aptorumgroup.com APM|Accounting Value per Share Lyra Therapeutics, Inc.|Accounting Value of a Share Impact BioMedical, Inc. IBO|TNFA - Book Value per Share|YCBD - Net Assets per Single Share|PainReform Limited - Book Value per Share|CYTO (Altamira Therapeutics Ltd.) - Net Assets per Share|Net Assets per Single Share LIPO (Lipella Pharmaceuticals)|Net Asset Value per Share optinose.com (OPTN)|Accounting Value per Share Pieris Pharmaceuticals, Inc.|Book Price of a Share Procaps Group (PROC)|PTPI: Book Value per Share|Net Asset Value per Share Qilian International Corp QLI|SLRN: Book Value per Share|TFFP - Accounting Value per Share